Alembic Pharmaceuticals has secured final approval for its abbreviated new drug application (ANDA) of Desonide Cream, 0.05% from the US Food and Drug Administration (FDA). The ANDA for the generic version of Padagis US’ Desonide Cream, 0.05% was filed by Aleor Dermaceuticals, which was merged with Alembic Pharmaceuticals. The approved product is a low potency […]
Alembic Pharmaceuticals said that its joint venture Aleor Dermaceuticals has secured final approval for Metronidazole Gel USP, 1 % from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA). According to Alembic Pharmaceuticals, the approved ANDA is the therapeutical equivalent to the reference listed drug product (RLD) — Metrogel Gel, […]
